Bcal Diagnostics Ltd Cash Flow-to-Debt Ratio
Bcal Diagnostics Ltd cash flow-to-debt ratio. Bcal Diagnostics Ltd (BDX) has a Cash Flow-to-Debt Ratio of -0.43x as of June 2026, meaning its operating cash flow of AU$-3.66 Million could theoretically repay 0% of its total liabilities (AU$8.49 Million) in one year. Check Bcal Diagnostics Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Bcal Diagnostics Ltd (2017–2025)
Cash flow-to-debt ratio of Bcal Diagnostics Ltd from 2017 to 2025. Historical debt coverage capacity for Bcal Diagnostics Ltd across 9 annual periods. See Bcal Diagnostics Ltd balance sheet independence to measure how much of total assets are equity-financed.
Bcal Diagnostics Ltd Cash Flow-to-Debt Ratio by Year (2017–2025)
Bcal Diagnostics Ltd cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for Bcal Diagnostics Ltd. For the full cash flow conversion analysis, see BDX cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.73x | AU$-6.16 Million | AU$8.49 Million | ▲ +56.4% |
| 2024 | -1.66x | AU$-6.14 Million | AU$3.69 Million | ▼ -35.3% |
| 2023 | -1.23x | AU$-4.52 Million | AU$3.68 Million | ▲ +35.8% |
| 2022 | -1.92x | AU$-6.05 Million | AU$3.16 Million | ▲ +43.4% |
| 2021 | -3.39x | AU$-3.22 Million | AU$950.42K | ▼ -47.6% |
| 2020 | -2.30x | AU$-1.21 Million | AU$525.60K | ▼ -32.0% |
| 2019 | -1.74x | AU$-661.65K | AU$380.64K | ▲ +82.7% |
| 2018 | -10.07x | AU$-525.01K | AU$52.14K | ▼ -1272.7% |
| 2017 | -0.73x | AU$-470.81K | AU$641.86K | — |